RALEIGH, N.C., July 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host an audio conference on the best practices for increasing clinical trial site and patient recruitment on 22 July 2010 at 11:30 am (EDT). PRA's senior vice president of Scientific and Medical Affairs, Kent Thoelke, will be the presenter.
Mr. Thoelke will discuss how the key to successful recruitment is using the right data and algorithms to locate the target patient population. The session will also review the top data-driven processes that can lead to fewer non-productive trial sites, shorter development timelines, greater patient recruitment and lower drug development costs.
Mr. Thoelke has 20 years of experience executing all aspects of global studies and directing programs within the biotech, pharma and CRO industries. He oversees PRA's Scientific and Medical Affairs unit, which includes our Therapeutic Expertise group as well as medical monitoring and patient recruitment. A leader in the development of evidence-based approaches in clinical research, Mr. Thoelke specializes in leveraging data to more effectively target patient accrual.
Comprised of board-certified physicians and industry experts, PRA's Therapeutic Expertise group provides scientific and medical expertise for global clinical development. The group covers a broad range of therapeutic areas and supports the operational delivery of clinical services. PRA provides services through all phases of drug development and in clinical medicine, biostatistics and regulatory submission strategies.
For more information about this audio conference, navigate to www.praintl.com and click on "Events." To register, email [email protected]. The registration deadline is Wednesday, 21 July 2010.
About PRA International
PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 38 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International
Advertisement
Mr. Thoelke will discuss how the key to successful recruitment is using the right data and algorithms to locate the target patient population. The session will also review the top data-driven processes that can lead to fewer non-productive trial sites, shorter development timelines, greater patient recruitment and lower drug development costs.
Advertisement
Mr. Thoelke has 20 years of experience executing all aspects of global studies and directing programs within the biotech, pharma and CRO industries. He oversees PRA's Scientific and Medical Affairs unit, which includes our Therapeutic Expertise group as well as medical monitoring and patient recruitment. A leader in the development of evidence-based approaches in clinical research, Mr. Thoelke specializes in leveraging data to more effectively target patient accrual.
Comprised of board-certified physicians and industry experts, PRA's Therapeutic Expertise group provides scientific and medical expertise for global clinical development. The group covers a broad range of therapeutic areas and supports the operational delivery of clinical services. PRA provides services through all phases of drug development and in clinical medicine, biostatistics and regulatory submission strategies.
For more information about this audio conference, navigate to www.praintl.com and click on "Events." To register, email [email protected]. The registration deadline is Wednesday, 21 July 2010.
About PRA International
PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 38 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International
